Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials

While quadruplet induction therapies deepen responses in newly diagnosed multiple myeloma patients, their impact on peripheral blood stem cell (PBSC) collection remains incompletely understood. This analysis aims to evaluate the effects of prolonged lenalidomide induction and isatuximab- or elotuzum...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kauer, Joseph (VerfasserIn) , Freundt, Emma Pauline (VerfasserIn) , Schmitt, Anita (VerfasserIn) , Weinhold, Niels (VerfasserIn) , Mai, Elias K. (VerfasserIn) , Müller-Tidow, Carsten (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn) , Raab, Marc-Steffen (VerfasserIn) , Kriegsmann, Katharina (VerfasserIn) , Sauer, Sandra (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 21 November 2023
In: BMC cancer
Year: 2023, Jahrgang: 23, Pages: 1-11
ISSN:1471-2407
DOI:10.1186/s12885-023-11507-9
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12885-023-11507-9
Volltext
Verfasserangaben:Joseph Kauer, Emma P. Freundt, Anita Schmitt, Niels Weinhold, Elias K. Mai, Carsten Müller-Tidow, Hartmut Goldschmidt, Marc S. Raab, Katharina Kriegsmann and Sandra Sauer

MARC

LEADER 00000caa a2200000 c 4500
001 1882368126
003 DE-627
005 20240307021553.0
007 cr uuu---uuuuu
008 240304s2023 xx |||||o 00| ||eng c
024 7 |a 10.1186/s12885-023-11507-9  |2 doi 
035 |a (DE-627)1882368126 
035 |a (DE-599)KXP1882368126 
035 |a (OCoLC)1425200444 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kauer, Joseph  |d 1992-  |e VerfasserIn  |0 (DE-588)1161466134  |0 (DE-627)102475524X  |0 (DE-576)50654382X  |4 aut 
245 1 0 |a Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients  |b a single centre experience from the GMMG-HD6 and -HD7 trials  |c Joseph Kauer, Emma P. Freundt, Anita Schmitt, Niels Weinhold, Elias K. Mai, Carsten Müller-Tidow, Hartmut Goldschmidt, Marc S. Raab, Katharina Kriegsmann and Sandra Sauer 
264 1 |c 21 November 2023 
300 |b Illustrationen 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.03.2024 
520 |a While quadruplet induction therapies deepen responses in newly diagnosed multiple myeloma patients, their impact on peripheral blood stem cell (PBSC) collection remains incompletely understood. This analysis aims to evaluate the effects of prolonged lenalidomide induction and isatuximab- or elotuzumab-containing quadruplet induction therapies on PBSC mobilization and collection. 
650 4 |a Elotuzumab 
650 4 |a Isatuximab 
650 4 |a Lenalidomide 
650 4 |a Multiple myeloma 
650 4 |a Stem cell mobilization 
700 1 |a Freundt, Emma Pauline  |d 1994-  |e VerfasserIn  |0 (DE-588)1245506609  |0 (DE-627)177717290X  |4 aut 
700 1 |a Schmitt, Anita  |d 1969-  |e VerfasserIn  |0 (DE-588)141722495  |0 (DE-627)630587752  |0 (DE-576)325593892  |4 aut 
700 1 |a Weinhold, Niels  |e VerfasserIn  |0 (DE-588)141225688  |0 (DE-627)626149576  |0 (DE-576)322607388  |4 aut 
700 1 |a Mai, Elias K.  |d 1985-  |e VerfasserIn  |0 (DE-588)1049182545  |0 (DE-627)781300274  |0 (DE-576)403130999  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
700 1 |a Raab, Marc-Steffen  |d 1973-  |e VerfasserIn  |0 (DE-588)124052460  |0 (DE-627)706520998  |0 (DE-576)293998027  |4 aut 
700 1 |a Kriegsmann, Katharina  |d 1986-  |e VerfasserIn  |0 (DE-588)1049422449  |0 (DE-627)781924006  |0 (DE-576)40339774X  |4 aut 
700 1 |a Sauer, Sandra  |d 1975-  |e VerfasserIn  |0 (DE-588)1060031140  |0 (DE-627)799171778  |0 (DE-576)416132855  |4 aut 
773 0 8 |i Enthalten in  |t BMC cancer  |d London : BioMed Central, 2001  |g 23(2023), Artikel-ID 1132, Seite 1-11  |h Online-Ressource  |w (DE-627)326643710  |w (DE-600)2041352-X  |w (DE-576)107014645  |x 1471-2407  |7 nnas  |a Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients a single centre experience from the GMMG-HD6 and -HD7 trials 
773 1 8 |g volume:23  |g year:2023  |g elocationid:1132  |g pages:1-11  |g extent:11  |a Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients a single centre experience from the GMMG-HD6 and -HD7 trials 
856 4 0 |u https://doi.org/10.1186/s12885-023-11507-9  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240304 
993 |a Article 
994 |a 2023 
998 |g 1060031140  |a Sauer, Sandra  |m 1060031140:Sauer, Sandra  |d 910000  |d 910100  |e 910000PS1060031140  |e 910100PS1060031140  |k 0/910000/  |k 1/910000/910100/  |p 10  |y j 
998 |g 1049422449  |a Kriegsmann, Katharina  |m 1049422449:Kriegsmann, Katharina  |d 50000  |e 50000PK1049422449  |k 0/50000/  |p 9 
998 |g 124052460  |a Raab, Marc-Steffen  |m 124052460:Raab, Marc-Steffen  |d 910000  |d 910100  |e 910000PR124052460  |e 910100PR124052460  |k 0/910000/  |k 1/910000/910100/  |p 8 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 1049182545  |a Mai, Elias K.  |m 1049182545:Mai, Elias K.  |d 910000  |d 910100  |d 50000  |e 910000PM1049182545  |e 910100PM1049182545  |e 50000PM1049182545  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 5 
998 |g 141225688  |a Weinhold, Niels  |m 141225688:Weinhold, Niels  |d 910000  |d 910100  |e 910000PW141225688  |e 910100PW141225688  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 141722495  |a Schmitt, Anita  |m 141722495:Schmitt, Anita  |d 910000  |d 910100  |d 50000  |e 910000PS141722495  |e 910100PS141722495  |e 50000PS141722495  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 3 
998 |g 1245506609  |a Freundt, Emma Pauline  |m 1245506609:Freundt, Emma Pauline  |d 910000  |d 910900  |e 910000PF1245506609  |e 910900PF1245506609  |k 0/910000/  |k 1/910000/910900/  |p 2 
998 |g 1161466134  |a Kauer, Joseph  |m 1161466134:Kauer, Joseph  |d 910000  |d 910100  |e 910000PK1161466134  |e 910100PK1161466134  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1882368126  |e 4495263994 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients","subtitle":"a single centre experience from the GMMG-HD6 and -HD7 trials","title_sort":"Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients"}],"language":["eng"],"person":[{"family":"Kauer","given":"Joseph","display":"Kauer, Joseph","role":"aut"},{"role":"aut","family":"Freundt","display":"Freundt, Emma Pauline","given":"Emma Pauline"},{"role":"aut","display":"Schmitt, Anita","given":"Anita","family":"Schmitt"},{"role":"aut","family":"Weinhold","given":"Niels","display":"Weinhold, Niels"},{"family":"Mai","display":"Mai, Elias K.","given":"Elias K.","role":"aut"},{"family":"Müller-Tidow","display":"Müller-Tidow, Carsten","given":"Carsten","role":"aut"},{"family":"Goldschmidt","given":"Hartmut","display":"Goldschmidt, Hartmut","role":"aut"},{"role":"aut","family":"Raab","display":"Raab, Marc-Steffen","given":"Marc-Steffen"},{"display":"Kriegsmann, Katharina","given":"Katharina","family":"Kriegsmann","role":"aut"},{"role":"aut","display":"Sauer, Sandra","given":"Sandra","family":"Sauer"}],"name":{"displayForm":["Joseph Kauer, Emma P. Freundt, Anita Schmitt, Niels Weinhold, Elias K. Mai, Carsten Müller-Tidow, Hartmut Goldschmidt, Marc S. Raab, Katharina Kriegsmann and Sandra Sauer"]},"origin":[{"dateIssuedDisp":"21 November 2023","dateIssuedKey":"2023"}],"recId":"1882368126","note":["Gesehen am 04.03.2024"],"relHost":[{"origin":[{"publisher":"BioMed Central ; Springer","dateIssuedDisp":"2001-","dateIssuedKey":"2001","publisherPlace":"London ; Berlin ; Heidelberg"}],"title":[{"title_sort":"BMC cancer","title":"BMC cancer"}],"part":{"pages":"1-11","extent":"11","year":"2023","text":"23(2023), Artikel-ID 1132, Seite 1-11","volume":"23"},"id":{"issn":["1471-2407"],"zdb":["2041352-X"],"eki":["326643710"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 22.05.20"],"disp":"Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients a single centre experience from the GMMG-HD6 and -HD7 trialsBMC cancer","recId":"326643710","language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2001 -"]}],"physDesc":[{"extent":"11 S.","noteIll":"Illustrationen"}],"id":{"eki":["1882368126"],"doi":["10.1186/s12885-023-11507-9"]},"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a KAUERJOSEPSTEMCELLCO2120